What does DIEPENBEEK MARKT FARMA do?

DIEPENBEEK MARKT FARMA is a logistics company in Diepenbeek. Public Limited, started on 27 October 1999, 1 establishment.

What is the address of DIEPENBEEK MARKT FARMA?

The registered office of DIEPENBEEK MARKT FARMA is located at Marktplein 20-21, 3590 Diepenbeek.

Is DIEPENBEEK MARKT FARMA still active?

Yes. According to the CBE (30 October 2026) DIEPENBEEK MARKT FARMA is active, legal situation “Normale toestand”, started on 27 October 1999.

Is DIEPENBEEK MARKT FARMA registered on Peppol?

Yes, DIEPENBEEK MARKT FARMA is registered on the Peppol network with ID 0208:0467158334.

What is the enterprise number of DIEPENBEEK MARKT FARMA?

The enterprise number of DIEPENBEEK MARKT FARMA is BE0467158334.

When was DIEPENBEEK MARKT FARMA founded?

DIEPENBEEK MARKT FARMA was founded on 27 October 1999.

Who are the directors of DIEPENBEEK MARKT FARMA?

According to the 2025 annual accounts, the directors of DIEPENBEEK MARKT FARMA are: Inge Philips, Krephi BV.

Is DIEPENBEEK MARKT FARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 October 1999; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DIEPENBEEK MARKT FARMA make in 2025?

DIEPENBEEK MARKT FARMA posted a profit after taxes of € 81,175 in financial year 2025.

What is the revenue of DIEPENBEEK MARKT FARMA?

As a small company, DIEPENBEEK MARKT FARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 224,604.

How much does an employee at DIEPENBEEK MARKT FARMA earn?

The average wage cost per full-time employee at DIEPENBEEK MARKT FARMA was € 53,300 in 2025: staff costs of € 101,328 for 1.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does DIEPENBEEK MARKT FARMA have?

According to the 2025 annual accounts, DIEPENBEEK MARKT FARMA has 1.9 full-time equivalents (FTE).

DIEPENBEEK MARKT FARMA (Public Limited) - Diepenbeek

Dossier DIEPENBEEK MARKT FARMA, printed on 30 October 2026 from databakkes.be/en/0467158334/diepenbeek-markt-farma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DIEPENBEEK MARKT FARMA from Diepenbeek, company number BE0467158334, closed financial year 2025 with a result of € 81,175 after tax. For that financial year DIEPENBEEK MARKT FARMA recorded a gross margin of € 224,604 and equity of € 242,155. Compared with financial year 2024, the result moved from € 148,515 to € 81,175. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.

What it is worth Healthy

€ 242,155

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 81,175

▼ 45% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 122,683

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 81,175 paid out

100 % of the profit went to the shareholders, mostly to KREPHI (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.9

▼ 1.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 101,328

▼ 1% vs 2024

€ 53,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,607

▼ 40% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 154,830

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,960

▲ 45% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 334,053 Gross margin 2022: € 334,053 First fiscal year in the series	€ 253,224 Gross margin 2023: € 253,224 ▼ 24% vs 2022 (€ 334,053) Unfavourable step	€ 277,489 Gross margin 2024: € 277,489 ▲ 10% vs 2023 (€ 253,224) Favourable step	€ 224,604 Gross margin 2025: € 224,604 ▼ 19% vs 2024 (€ 277,489) Unfavourable step	▼ 19%
Profit after taxes	€ 76,726 Profit after taxes 2022: € 76,726 First fiscal year in the series	€ 17,962 Profit after taxes 2023: € 17,962 ▼ 77% vs 2022 (€ 76,726) Unfavourable step	€ 148,515 Profit after taxes 2024: € 148,515 ▲ € 130,554 vs 2023 (€ 17,962) Favourable step	€ 81,175 Profit after taxes 2025: € 81,175 ▼ 45% vs 2024 (€ 148,515) Unfavourable step	▼ 45%
Equity	€ 205,678 Equity 2022: € 205,678 First fiscal year in the series	€ 213,640 Equity 2023: € 213,640 ▲ 4% vs 2022 (€ 205,678) Favourable step	€ 242,155 Equity 2024: € 242,155 ▲ 13% vs 2023 (€ 213,640) Favourable step	€ 242,155 Equity 2025: € 242,155 Unchanged (€ 242,155) Unchanged
Total debts	€ 352,252 Total debts 2022: € 352,252 First fiscal year in the series	€ 227,312 Total debts 2023: € 227,312 ▼ 35% vs 2022 (€ 352,252) Favourable step	€ 298,440 Total debts 2024: € 298,440 ▲ 31% vs 2023 (€ 227,312) Unfavourable step	€ 263,753 Total debts 2025: € 263,753 ▼ 12% vs 2024 (€ 298,440) Favourable step	▼ 12%
Cash	€ 274,009 Cash 2022: € 274,009 First fiscal year in the series	€ 71,093 Cash 2023: € 71,093 ▼ 74% vs 2022 (€ 274,009) Unfavourable step	€ 122,485 Cash 2024: € 122,485 ▲ 72% vs 2023 (€ 71,093) Favourable step	€ 122,683 Cash 2025: € 122,683 Unchanged (€ 122,485) Favourable step
Retained profit	€ 143,705 Retained profit 2022: € 143,705 First fiscal year in the series	€ 151,666 Retained profit 2023: € 151,666 ▲ 6% vs 2022 (€ 143,705) Favourable step	€ 180,182 Retained profit 2024: € 180,182 ▲ 19% vs 2023 (€ 151,666) Favourable step	€ 180,182 Retained profit 2025: € 180,182 Unchanged (€ 180,182) Unchanged
Dividend	€ 210,000 Dividend 2022: € 210,000 First fiscal year in the series	€ 10,000 Dividend 2023: € 10,000 ▼ 95% vs 2022 (€ 210,000) Unchanged	€ 120,000 Dividend 2024: € 120,000 ▲ € 110,000 vs 2023 (€ 10,000) Unchanged	€ 81,175 Dividend 2025: € 81,175 ▼ 32% vs 2024 (€ 120,000) Unchanged	▼ 32%
Balance sheet total	€ 557,930 Balance sheet total 2022: € 557,930 First fiscal year in the series	€ 440,952 Balance sheet total 2023: € 440,952 ▼ 21% vs 2022 (€ 557,930) Unchanged	€ 540,595 Balance sheet total 2024: € 540,595 ▲ 23% vs 2023 (€ 440,952) Unchanged	€ 505,908 Balance sheet total 2025: € 505,908 ▼ 6% vs 2024 (€ 540,595) Unchanged	▼ 6%
Employees (FTE)	3.8 Employees (FTE) 2022: 3.8 First fiscal year in the series	3.5 Employees (FTE) 2023: 3.5 ▼ 0.3 vs 2022 (3.8) Unchanged	3.5 Employees (FTE) 2024: 3.5 Unchanged (3.5) Unchanged	1.9 Employees (FTE) 2025: 1.9 ▼ 1.6 vs 2024 (3.5) Unchanged	▼ 1.6

Key figures of DIEPENBEEK MARKT FARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DIEPENBEEK MARKT FARMA?

What happened at DIEPENBEEK MARKT FARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 4, 2026 New annual accounts for financial year 2025: profit of € 81,175 (▼ 45% vs 2024). Source: NBB ↗
2023 Inge Philips became a director. NBB
2023 Krephi BV became a director. NBB
Dec 3, 1999 New establishment in Diepenbeek. KBO
Oct 27, 1999 Start of the company according to the CBE. KBO

In short

From € 76,726 profit in 2022 to € 81,175 profit in 2025.

Paid € 38,676 in corporate taxes since 2022.

Best year ever: 2024, with € 148,515 profit.

On average € 118,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

KREPHI 100%

The stake of KREPHI comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

DIEPENBEEK MARKT FARMA

Behind DIEPENBEEK MARKT FARMA are Inge Philips and Krephi BV. The shares are held by KREPHI (100%).

Directors

According to the 2025 annual accounts

Inge Philips

Director

Also active at: KREPHI

since 2023

Krephi BV

Director · represented by Koen Kreemers

since 2023

Shareholders

KREPHI

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Marktplein 20-21

3590 Diepenbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0467.158.334

VAT number

BE 0467.158.334

Registered office

Marktplein 20-21, 3590 Diepenbeek

Names & denominations

DIEPENBEEK MARKT FARMA · DMF

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

27 October 1999

Peppol

Active · Active since 8 Jan 2026

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Groothandel in parfumerieën en cosmetica

Groothandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗